Skip to main content

Advertisement

Table 2 Number of persons interviewed by Household or by Location and recalling taking both ivermectin and albendazole by area, day and compliance (%) for Day 1 and Day 2 End Process.

From: High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone

  Sample size as % of treatments Sample size as % of eligible pop Day 1: End Process Day 2 End Process: Hard to Reach Total Day 1 & 2: End Process
UWA    Interview Recall % Interview Recall % Interview Recall %
Household    460 371 80.7 530 418 78.9 990 789 79.7
Location    2734 2332 85.3 2613 2275 87.1 5347 4607 86.2
Subtotal 0.74% 0.86% 3194 2703 84.6 3143 2693 85.7 6337 5396 85.2
RWA            
Household    267 236 88.4 281 244 86.8 548 480 87.6
Location    1056 907 85.9 1308 1150 87.9 2364 2057 87.0
Subtotal 1.20% 1.55% 1323 1143 86.4 1589 1394 87.7 2912 2537 87.1
Total 0.84% 1.00% 4517 3846 85.1 4732 4087 86.4 9249 7933 85.8